Biopharmaceuticals

Cassava shares plummet after investigation accuses researcher of ‘egregious misconduct’

Amgen to proceed to hunt full approval of Lumakras most cancers drug after FDA panel votes in opposition to it

As Medicare drug-price negotiations inch ahead, some states are flexing new powers to chop prices for a broader swath of medication 

As COVID hospitalizations rise, Pfizer and Moderna say up to date pictures present promise in opposition to Eris variant

Here are the 20 finest performing shares of March — and the 20 worst

Stock market volatility this week has triggered a brand new promote sign

Amgen to chop about 450 jobs in second spherical of layoffs this yr

SVB’s rescue means the Fed will not hike charges in March, says Goldman Sachs

‘Upload your thoughts’ or alter genetics: Powerful billionaires are pouring cash into life-extending expertise — they usually simply would possibly succeed.

AstraZeneca says most cancers drug Enhertu confirmed optimistic outcomes